Dihydropyrimidines and uses thereof

Abstract

This invention is directed to dihydropyrimidines which are selective antagonists for human α1a receptors. This invention is also related to uses of these compounds for relaxing lower urinary tract tissue, treating benign prostatic hyperplasia and for the treatment of any disease where the antagonism of the α1a receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Dependencies are inferred from the claim text.